HK27894A - Preservative system for ophtalmic formulations - Google Patents

Preservative system for ophtalmic formulations

Info

Publication number
HK27894A
HK27894A HK278/94A HK27894A HK27894A HK 27894 A HK27894 A HK 27894A HK 278/94 A HK278/94 A HK 278/94A HK 27894 A HK27894 A HK 27894A HK 27894 A HK27894 A HK 27894A
Authority
HK
Hong Kong
Prior art keywords
formulations
preservative system
ophtalmic
preservative
caused
Prior art date
Application number
HK278/94A
Other languages
English (en)
Inventor
Fu Cherng-Chyi Roger
Deborah M Lidgate
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22256043&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK27894(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of HK27894A publication Critical patent/HK27894A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Detergent Compositions (AREA)
HK278/94A 1987-09-11 1994-03-24 Preservative system for ophtalmic formulations HK27894A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9617387A 1987-09-11 1987-09-11

Publications (1)

Publication Number Publication Date
HK27894A true HK27894A (en) 1994-03-31

Family

ID=22256043

Family Applications (1)

Application Number Title Priority Date Filing Date
HK278/94A HK27894A (en) 1987-09-11 1994-03-24 Preservative system for ophtalmic formulations

Country Status (17)

Country Link
EP (1) EP0306984B1 (fi)
JP (1) JPH0696542B2 (fi)
KR (1) KR950013754B1 (fi)
AT (1) ATE74750T1 (fi)
AU (1) AU626798B2 (fi)
CA (1) CA1328614C (fi)
DE (1) DE3870111D1 (fi)
DK (1) DK174702B1 (fi)
FI (1) FI94924C (fi)
HK (1) HK27894A (fi)
HU (2) HU199072B (fi)
IE (1) IE60717B1 (fi)
IL (1) IL87724A (fi)
NO (1) NO175404C (fi)
NZ (1) NZ226100A (fi)
PH (1) PH25422A (fi)
ZA (1) ZA886757B (fi)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5414011A (en) * 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
EP0420798B1 (de) * 1989-09-21 1994-03-23 Ciba Vision AG, Hettlingen Antimikrobielle Zusammensetzungen
IL95942A0 (en) * 1989-10-13 1991-07-18 Syntex Inc Collagen-containing ophthalmic formulation
WO1991013609A1 (en) * 1990-03-16 1991-09-19 The Procter & Gamble Company Use of ketorolac for treatment of periodontal disease
US5464609A (en) * 1990-03-16 1995-11-07 The Procter & Gamble Company Use of ketorolac for treatment of oral diseases and conditions
BR9107284A (pt) * 1990-12-27 1994-09-27 Allergan Inc Processo para desinfetar lentes de contato, e, solução desinfetante de lentes de contato.
US5093105A (en) * 1991-04-09 1992-03-03 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats
US5227152A (en) * 1991-04-09 1993-07-13 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats
US5306482A (en) * 1991-04-09 1994-04-26 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats
WO1995016435A2 (en) * 1993-12-17 1995-06-22 Alcon Laboratories, Inc. Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
US5474985A (en) * 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
ES2079320B1 (es) * 1994-05-17 1996-10-16 Cusi Lab Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
WO1995033456A2 (en) * 1994-06-07 1995-12-14 Telor Ophthalmic Pharmaceuticals, Inc. Reducing intraocular pressure using aryloxy- and aryl-acetic acids
CA2201134A1 (en) * 1994-10-10 1996-04-18 Alfred Sallmann Ophthalmic and aural compositions containing diclofenac potassium
US5603929A (en) * 1994-11-16 1997-02-18 Alcon Laboratories, Inc. Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
ATE215821T1 (de) * 1995-01-20 2002-04-15 Wakamoto Pharma Co Ltd Entzündungshemmende augentropfen
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
JPH09278653A (ja) * 1996-04-05 1997-10-28 Santen Pharmaceut Co Ltd 網膜疾患治療剤
MX9701946A (es) * 1997-03-14 1998-04-30 Arturo Jimenez Bayardo Solucion oftalmica transportadora.
DE19729879C2 (de) * 1997-07-11 1999-07-08 Mann Gerhard Chem Pharm Fab Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin
JP2006111636A (ja) * 1997-12-26 2006-04-27 Astellas Pharma Inc 徐放性医薬組成物
WO2000051620A1 (en) * 1999-03-02 2000-09-08 Vitreo-Retinal Technologies, Inc. Agents for intravitreal administration to treat or prevent disorders of the eye
DE19918324A1 (de) * 1999-04-22 2000-10-26 Mann Gerhard Chem Pharm Fab Pharmazeutische Zusammensetzung wirksam gegen durch Bakterien, Viren, Pilze, Hefen und Protozoen verursachte Krankheitszustände
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
JP4500261B2 (ja) * 2003-01-21 2010-07-14 千寿製薬株式会社 ２−アミノ−３−（４−ブロモベンゾイル）フェニル酢酸含有水性液剤
US8008338B2 (en) 2003-06-03 2011-08-30 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
DK1654002T4 (da) 2003-08-07 2014-02-17 Allergan Inc Sammensætninger til fremføring af terapeutiske midler til øjnene
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
US20050261243A1 (en) * 2004-04-21 2005-11-24 Peyman Gholam A Antiprostaglandins for the treatment of ocular pathologies
US9161905B2 (en) * 2005-01-12 2015-10-20 Ocular Research Of Boston, Inc. Dry eye treatment
US9192571B2 (en) 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
JP5559339B2 (ja) 2009-10-12 2014-07-23 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む組成物のための容器
BR112012022073A2 (pt) 2010-03-03 2017-10-31 Boehringer Ingelheim Vetmedica Gmbh uso de meloxicam para o tratamento de longa duração de distúrbios musculoesqueletais em gatos.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
JP2013082682A (ja) * 2011-09-29 2013-05-09 Senju Pharmaceut Co Ltd 亜塩素酸塩を含有する水性製剤
CN110448530A (zh) * 2018-05-07 2019-11-15 北京蓝丹医药科技有限公司 一种氟比洛芬酯注射液

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087538A (en) * 1976-09-09 1978-05-02 Merck & Co., Inc. Ophthalmic suspensions
DE3026402A1 (de) * 1980-07-11 1982-02-04 Syntex Corp., Palo Alto, Calif. Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen
JPS61501566A (ja) * 1984-03-14 1986-07-31 コルビエ−ル　ジエロ−ム 有効成分の可溶化法およびそれにより得られる薬理組成物

Also Published As

Publication number Publication date
DK505688A (da) 1989-03-12
NO884020D0 (no) 1988-09-09
NO175404B (no) 1994-07-04
FI94924C (fi) 1995-11-27
ATE74750T1 (de) 1992-05-15
IL87724A0 (en) 1989-02-28
DK174702B1 (da) 2003-09-29
HU199072B (en) 1990-01-29
PH25422A (en) 1991-07-01
EP0306984A1 (en) 1989-03-15
JPH01104023A (ja) 1989-04-21
IL87724A (en) 1992-01-15
CA1328614C (en) 1994-04-19
ZA886757B (en) 1990-05-30
KR890004691A (ko) 1989-05-09
FI884160A (fi) 1989-03-12
DE3870111D1 (de) 1992-05-21
FI884160A0 (fi) 1988-09-09
AU2204288A (en) 1989-03-16
NO175404C (no) 1994-10-12
FI94924B (fi) 1995-08-15
JPH0696542B2 (ja) 1994-11-30
HU210610A9 (en) 1995-05-29
DK505688D0 (da) 1988-09-09
IE60717B1 (en) 1994-08-10
IE882740L (en) 1989-03-11
KR950013754B1 (ko) 1995-11-15
HUT47839A (en) 1989-04-28
NO884020L (no) 1989-03-13
NZ226100A (en) 1990-12-21
AU626798B2 (en) 1992-08-13
EP0306984B1 (en) 1992-04-15

Similar Documents

Publication Publication Date Title
HK27894A (en) Preservative system for ophtalmic formulations
CA2013188A1 (en) Preservative system for ophthalmic formulations
KR100260061B1 (en) Vitamin e drop
DE3152759T1 (de) Flexible intraokulare linse
NO960207D0 (no) Oftalmisk lösning basert på diklofenak og tobramycin samt anvendelse av denne
DE69333927D1 (de) Agglomerierte hydrophile Komplexe mit mehrphasigen Abgabeeigenschaften
ES2048415T3 (es) Dispositivo de conformacion corneal automatico.
LV10688A (lv) Pretalergisks sastavs oftalmologijai vai deguna slimibam
DE69630325D1 (de) Nervenschutzende für Auge von Säugern unter Anwendung von Kaliumkanalblockern
ES2131373T3 (es) Composicion oftalmica para prevenir o tratar el ojo seco o una enfermedad causada por el mismo, que comprende acido 12-sulfodeshidroabietico.
CA2129635A1 (en) Method of Ophthalmic Drug Delivery
DE69737421T2 (de) Intraokulare linse mit abzugebendem medikament
DE69013431D1 (de) Anthocyanidine zur Behandlung von Augenkrankheiten.
Joo et al. Outflow of aqueous humor following cyclodialysis or ciliochoroidal detachment in rabbit
SU1357021A1 (ru) Средство, уменьшающее проницаемость капилл ров, снижающее агрегацию тромбоцитов, дл лечени внутриглазных кровоизли ний
EIM et al. EVALUATION OF GENTA MICIN SULFATE IN AQUEOUS HUMOR OF DONKEYS FOLLOWING ITS ADMINISTRATION
Habegger VEGETATIVE PHYSIOLOGY, BIOCHEM-ISTRY, PHARMACOLOGY, TOXICOLOGY
JPS574920A (en) Prescription of 5-fluoro-2-methyl-1- (p-methylthiobenzylidene)-3-indenylacetic acid
Gelatt Multifocal ocular histoplasmosis in a dog and cat: by RM Gwin, Torrence A. Makley, Jr., Milton Wyman, and Kathryn Werling. J Am Vet Med Assoc 176: 638–642, 1980
Nagao Primate eye fields in the deep cerebellar nuclei determined by local stimulation technique
Kobayashi et al. Climbing fiber inputs to monkey cerebellar ventral paraflocculus during ocular following responses
IT1241928B (it) Composizione oftalmica per l'uso nel mantenimento della midriasi oculare
PT88472A (pt) Metodo para o tratamento da mastite e outras infeccoes estafilococais

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20080908